The British Pharmacopoeia

The BP makes an important contribution to the role of the Medicines and Healthcare products Regulatory Agency (MHRA) in protecting public health by providing quality standards for UK pharmaceutical substances and medicinal products.

The BP has a wide international reach and:

  • is used in over 100 countries
  • forms an inherent part of established medicines legislation in Commonwealth countries
  • provides expert advice to the European Pharmacopoeia and plays a significant role in the standard-setting process in Europe
  • provides expert advice to the World Health Organization
  • has strong links with leading world pharmacopoeias, ensuring the quality of medicines is always at the forefront of international discussions

Buy the latest edition of the BP.

The BP has been providing official standards for medicines since 1864. The legal status of the British Pharmacopoeia Commission and of the British Pharmacopoeia was established under the 1968 Medicines Act. This Act has been superseded by the Human Medicines Regulations 2012.

Statement on EU referendum from the British Pharmacopoeia

We have published an Updated statement on exiting the EU, and the British Pharmacopoeia, to help provide additional clarity.

Read our original Statement on the outcome of the EU referendum. You can also read the full statement MHRA and making a success of Brexit.